Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer by Hanshen Yang, Xiaozhen Zhang, Sirui Zhang, Yanqing Yang, Yan Chen, Yangwei Jiang, Qingsong Lu, Lingyue Liu, Mengyi Lao, Weiran Du, Kang Sun, Lihong He, Jiatao Shi, Xinyuan Liu, Jinyuan Song, Na Lu, Junming Huang, Jinyan Huang, Ruhong Zhou, Xiongbin Lu, Tingbo Liang, Xueli Bai

“…Analysis of polyamines in the plasma of pancreatic cancer patients reveals that spermine levels are significantly elevated and correlate with poor prognosis. …”
Get full text

Optimization of electrode position in electric field treatment for pancreatic cancer by Sangcheol Kim, Yousun Ko, Dongho Shin, Haksoo Kim, Sung Uk Lee, Jonghyun Kim, Tae Hyun Kim, Myonggeun Yoon

Subjects: Get full text

FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer by Stefan N. Symeonides, Stephen M. Anderton, Alan Serrels

“…Immunotherapy has had remarkable success in the treatment of some cancer types. However, pancreatic cancer has remained largely refractory to immunotherapy, including immune checkpoint inhibitors. …”
Get full text

Current Trends and Future Directions in Pancreatic Cancer Management: Review by Wojciech Firlej, Michał Nowak, Barbara Ufnalska, Anna Konarska, Anna Machowiak, Artur Fabijański, Mateusz Janik, Justyna Lisiecka, Joanna Rychlewska-Duda, Adriana Dukacz

“…Introduction: Pancreatic cancer remains one of the most aggressive and lethal malignancies, characterized by late diagnosis, limited treatment options, and a poor overall prognosis. …”
Get full text

Bibliometric analysis of clinical trials of Chinese medicine for pancreatic cancer by YU Jiahui, TIAN Shaodan, WANG Xuzhe, WU Rixin, CHEN Xinyi

Subjects: Get full text

The impact of distress at diagnosis in patients with pancreatic cancer undergoing pancreatectomy by So Jeong Yoon, Soo Yeun Lim, HyeJeong Jeong, Hochang Chae, Hyeong Seok Kim, So Kyung Yoon, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, In Woong Han

Subjects: “…Pancreatic cancer…”
Get full text

Decoding the pancreatic cancer microenvironment: The multifaceted regulation of microRNAs by Jie Ji, Dandan Jin, Junpeng Zhao, Xudong Xie, Yujie Jiao, Xuyang He, Yuxuan Huang, Lirong Zhou, Mingbing Xiao, Xiaolei Cao

“…Abstract Pancreatic cancer (PC) is an extremely deadly type of cancer, and the 5‐year survival rate remains less than 10%. …”
Get full text

The therapeutic potential of vitamins A, C, and D in pancreatic cancer by Alban Piotrowsky, Markus Burkard, Hendrik Schmieder, Sascha Venturelli, Olga Renner, Luigi Marongiu

Subjects: Get full text

Impact of Preoperative Weight Loss on Prognosis in Patients with Pancreatic Cancer by Mariko Tsukagoshi, Kenichiro Araki, Norio Kubo, Takamichi Igarashi, Shunsuke Kawai, Kei Hagiwara, Kouki Hoshino, Takaomi Seki, Takayuki Okuyama, Ryosuke Fukushima, Takahiro Shoda, Ken Shirabe

Subjects: Get full text

A PARADIGM SHIFT IN THE TREATMENT OF PATIENTS WITH RESECTABLE PANCREATIC CANCER by E. Yu. Antonova, I. S. Bazin, A. M. Garin, I. A. Pokataev, I. B. Sagaidak, A. N. Polyakov, Y. E. Chihareva, A. Yu. Volkov, I. V. Bazina

Subjects: “…pancreatic cancer…”
Get full text

Feasibility analysis and development trend of nanomaterials for the treatment of pancreatic cancer by Jingyao Zhu, Yue Li, Xiaoqing Li, Yong Wang, Qixiang Liu, Yang Yang, HongJian Guan

Subjects: “…Pancreatic cancer…”
Get full text

Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer by Geng Xu, Yaling Jiang, Chen Sun, Bernd W. Brandt, Kamran Nazmi, Luca Morelli, Giulia Lencioni, Elisa Giovannetti, Dongmei Deng

Subjects: “…pancreatic cancer…”
Get full text

PRELIMINARY EVALUATION OF THE EFFECTIVENESS OF HIFU-THERAPY IN PATIENTS WITH PANCREATIC CANCER by L. B. Bolotina, L. I. Moskvicheva, A. L. Kornietskaya, D. V. Sidorov, N. A. Grishin, M. V. Lozhkin, A. D. Kaprin

Subjects: “…pancreatic cancer…”
Get full text

The Interplay Between DNA Repair and the Immune Microenvironment in Pancreatic Cancer by Aaron Ciner, Peter J. Hosein, Yixing Jiang, Feyruz Rassool

Subjects: “…pancreatic cancer…”
Get full text

CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target by Cong Xiao, Xiaojuan Zhang, Bobo Hou, Ping Wan, Zhenjun Cao, Xuefeng Rao

“…However, the prognostic potential of CYFIP2 in pancreatic cancer remains unclear. In this work, we first explain the great potential of CYFIP2 malignant progression from a broader perspective (pan-cancer) and confirm its oncogenic value in pancreatic cancer. …”
Get full text

Sarcopenia as a predictor of postoperative complications in patients with pancreatic cancer by V.M. Kopchak, L.O. Pererva, V.P. Shkarban, V.I. Trachuk, S.V. Lynnyk

“…Sarcopenia significantly affects the level of postoperative complications and its detection can be used to improve the selection of patients before pancreatic resections in patients with pancreatic cancer.…”
Get full text

The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer by Federica Vitale, Lorenzo Zileri Dal Verme, Mattia Paratore, Marcantonio Negri, Enrico Celestino Nista, Maria Elena Ainora, Giorgio Esposto, Irene Mignini, Raffaele Borriello, Linda Galasso, Sergio Alfieri, Antonio Gasbarrini, Maria Assunta Zocco, Alberto Nicoletti

Subjects: “…pancreatic cancer…”
Get full text

Prolonged survival in metastatic pancreatic cancer: a case of multimodal therapy by Trishtha Agarwal, Kaandeeban Mohanraj, Ananth Pai

“…Introduction: Pancreatic ductal adenocarcinoma (PDACs) encompasses > 85% of pancreatic cancers and represents one of the most aggressive malignancies with poor prognosis and the lowest survival rates of <5%. …”
Get full text

Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer by Alok Ranjan, Nadezhda German, Constantinos Mikelis, Kalkunte Srivenugopal, Sanjay K Srivastava

“…Pancreatic cancer is one of the most aggressive and difficult to treat cancers. …”
Get full text

Unveiling Microbiota Profiles in Saliva and Pancreatic Tissues of Patients with Pancreatic Cancer by Alper Uguz, Can Muftuoglu, Ufuk Mert, Tufan Gumus, Deniz Ece, Milad Asadi, Ozlem Ulusan Bagci, Ayse Caner

“…This study emphasizes the importance of understanding the role of body fluid and tissue microbiota in pancreatic cancer, proposing that oral dysbiosis may contribute to disease progression. …”
Get full text